Preferential development of pre-B lymphomas with drastically down-regulated N-myc in the E mu-ret transgenic mice.
about
Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.Oncogene-linked in situ immunotherapy of pre-B lymphoma arising in E mu/ret transgenic miceMammalian target of rapamycin (mTOR) pathway signalling in lymphomas.CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene.
P2860
Preferential development of pre-B lymphomas with drastically down-regulated N-myc in the E mu-ret transgenic mice.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Preferential development of pr ...... the E mu-ret transgenic mice.
@en
type
label
Preferential development of pr ...... the E mu-ret transgenic mice.
@en
prefLabel
Preferential development of pr ...... the E mu-ret transgenic mice.
@en
P2093
P356
P1476
Preferential development of pr ...... the E mu-ret transgenic mice.
@en
P2093
Ichihara M
Kawashima K
Nakashima I
Takahashi M
P2860
P304
P356
10.1002/EJI.1830210805
P407
P577
1991-08-01T00:00:00Z